Literature DB >> 34616083

A step towards therapeutics for dengue.

Scott B Biering, Eva Harris.   

Abstract

Entities:  

Keywords:  Drug discovery; Infection; Virology

Mesh:

Year:  2021        PMID: 34616083     DOI: 10.1038/d41586-021-02638-9

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  Targeting dengue virus NS4B protein for drug discovery.

Authors:  Xuping Xie; Jing Zou; Qing-Yin Wang; Pei-Yong Shi
Journal:  Antiviral Res       Date:  2015-03-19       Impact factor: 5.970

2.  Inhibition of dengue virus by targeting viral NS4B protein.

Authors:  Xuping Xie; Qing-Yin Wang; Hao Ying Xu; Min Qing; Laura Kramer; Zhiming Yuan; Pei-Yong Shi
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

3.  Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.

Authors:  Ilane Hernandez-Morales; Peggy Geluykens; Marleen Clynhens; Rudy Strijbos; Olivia Goethals; Sarah Megens; Nick Verheyen; Stefaan Last; David McGowan; Erwin Coesemans; Benoît De Boeck; Bart Stoops; Benoit Devogelaere; Frederik Pauwels; Koen Vandyck; Jan Martin Berke; Pierre Raboisson; Kenneth Simmen; Pedro Lory; Marnix Van Loock
Journal:  Antiviral Res       Date:  2017-10-14       Impact factor: 5.970

4.  NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models.

Authors:  Stephanie A Moquin; Oliver Simon; Ratna Karuna; Suresh B Lakshminarayana; Fumiaki Yokokawa; Feng Wang; Chandra Saravanan; Jin Zhang; Craig W Day; Katherine Chan; Qing-Yin Wang; Siyan Lu; Hongping Dong; Kah Fei Wan; Siew Pheng Lim; Wei Liu; Cheah Chen Seh; Yen-Liang Chen; Haoying Xu; David T Barkan; Cyrille S Kounde; Wei Lin Sandra Sim; Gang Wang; Hui-Quan Yeo; Bin Zou; Wai Ling Chan; Mei Ding; Jae-Geun Song; Min Li; Colin Osborne; Francesca Blasco; Christopher Sarko; David Beer; Ghislain M C Bonamy; Vito G Sasseville; Pei-Yong Shi; Thierry T Diagana; Bryan K S Yeung; Feng Gu
Journal:  Sci Transl Med       Date:  2021-02-03       Impact factor: 17.956

5.  Discovery of Dengue Virus NS4B Inhibitors.

Authors:  Qing-Yin Wang; Hongping Dong; Bin Zou; Ratna Karuna; Kah Fei Wan; Jing Zou; Agatha Susila; Andy Yip; Chao Shan; Kim Long Yeo; Haoying Xu; Mei Ding; Wai Ling Chan; Feng Gu; Peck Gee Seah; Wei Liu; Suresh B Lakshminarayana; CongBao Kang; Julien Lescar; Francesca Blasco; Paul W Smith; Pei-Yong Shi
Journal:  J Virol       Date:  2015-08       Impact factor: 5.103

6.  Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors.

Authors:  Dorothée Bardiot; Mohamed Koukni; Wim Smets; Gunter Carlens; Michael McNaughton; Suzanne Kaptein; Kai Dallmeier; Patrick Chaltin; Johan Neyts; Arnaud Marchand
Journal:  J Med Chem       Date:  2018-09-12       Impact factor: 7.446

7.  A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients.

Authors:  Nguyet Minh Nguyen; Chau Nguyen Bich Tran; Lam Khanh Phung; Kien Thi Hue Duong; Huy le Anh Huynh; Jeremy Farrar; Quyen Than Ha Nguyen; Hien Tinh Tran; Chau Van Vinh Nguyen; Laura Merson; Long Truong Hoang; Martin L Hibberd; Pauline P K Aw; Andreas Wilm; Niranjan Nagarajan; Dung Thi Nguyen; Mai Phuong Pham; Truong Thanh Nguyen; Hassan Javanbakht; Klaus Klumpp; Janet Hammond; Rosemary Petric; Marcel Wolbers; Chinh Tran Nguyen; Cameron P Simmons
Journal:  J Infect Dis       Date:  2012-07-17       Impact factor: 5.226

8.  Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials.

Authors:  Cameron P Simmons; Marcel Wolbers; Minh Nguyet Nguyen; Jamie Whitehorn; Pei Yong Shi; Paul Young; Rosemary Petric; Van Vinh Chau Nguyen; Jeremy Farrar; Bridget Wills
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

9.  Antibody-dependent enhancement of severe dengue disease in humans.

Authors:  Leah C Katzelnick; Lionel Gresh; M Elizabeth Halloran; Juan Carlos Mercado; Guillermina Kuan; Aubree Gordon; Angel Balmaseda; Eva Harris
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

Review 10.  Current Status of Dengue Therapeutics Research and Development.

Authors:  Jenny G H Low; Eng Eong Ooi; Subhash G Vasudevan
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

  10 in total
  2 in total

Review 1.  Structures and Dynamics of Dengue Virus Nonstructural Membrane Proteins.

Authors:  Qingxin Li; Congbao Kang
Journal:  Membranes (Basel)       Date:  2022-02-17

Review 2.  Dengue virus NS4B protein as a target for developing antivirals.

Authors:  Qingxin Li; Congbao Kang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-09       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.